BC
MEDP icon

Bayforest Capital’s Medpace MEDP Stock Holding History

Bayforest Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Sell
595
-36
-6% -$16.6K 0.29% 58
2026
Q1 		$303K Sell
631
-85
-12% -$43.5K 0.34% 33
2025
Q4 		$402K Sell
716
-1,025
-59% -$582K 0.3% 66
2025
Q3 		$895K Buy
1,741
+1,721
+8,605% +$751K 0.43% 28
2025
Q2 		$6.28K Sell
20
-1,678
-99% -$504K ﹤0.01% 662
2025
Q1 		$517K Buy
1,698
+1,400
+470% +$471K 0.23% 154
2024
Q4 		$99K Buy
+298
New +$101K 0.12% 313

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bayforest Capital's MEDP Position: Q2 2026 in Review

Bayforest Capital reduced its Medpace (MEDP) stake by 5.7% in Q2 2026, selling an estimated $16.6K and leaving 595 shares worth $315K. The position accounts for 0.29% of the portfolio, ranked #58.

Bayforest Capital first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $895K in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bayforest Capital held 595 shares of Medpace worth $315K as of Q2 2026.
  • Bayforest Capital sold 36 Medpace shares in Q2 2026, an estimated $16.6K.
  • Medpace made up 0.29% of Bayforest Capital's portfolio in Q2 2026, its #58 holding.
  • Bayforest Capital first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Bayforest Capital's Medpace position peaked at $895K in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.